Electron activated dissociation (EAD) and the Zeno trap provide high sensitivity and certainty in mass spectrometry results. 

Clean room equipment is a leading source of particulate contamination for cell-based biologics manufacturing.

A closed and scalable electroporation system is an example of how innovation can boost clinical manufacturing efficiency.

Explore what makes an effective and efficient cell therapy manufacturing workflow.

3-D cell culture systems open new possibilities for recombinant protein production.

Discover how you can design and generate genomic edits to optimize heterologous protein expression and activity in E. coli.

How automated liquid handling accelerates plasmid purification.

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

Delivering a missing enzyme to the brains of paralyzed children with a rare, life-threatening neurological disease restores movement and builds muscle mass.

The US Food and Drug Administration has relaxed some of the rules governing how companies must test the sterility of materials used to make biologic drugs.

Large molecules are more likely to make it to market these days than small molecules, according to new reports.

The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.